Compare VIK & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VIK | IDXX |
|---|---|---|
| Founded | 1997 | 1983 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.6B | 43.6B |
| IPO Year | 2023 | 1996 |
| Metric | VIK | IDXX |
|---|---|---|
| Price | $96.67 | $564.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 9 |
| Target Price | $84.14 | ★ $721.67 |
| AVG Volume (30 Days) | ★ 2.5M | 631.0K |
| Earning Date | 05-19-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | N/A | ★ 3.47 |
| Revenue | N/A | ★ $4,303,702,000.00 |
| Revenue This Year | $14.41 | $10.88 |
| Revenue Next Year | $14.16 | $8.59 |
| P/E Ratio | ★ $37.68 | $165.77 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $55.55 | $513.78 |
| 52 Week High | $105.76 | $769.98 |
| Indicator | VIK | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 48.40 | 53.01 |
| Support Level | $96.63 | $553.20 |
| Resistance Level | $105.76 | $584.57 |
| Average True Range (ATR) | 2.88 | 18.14 |
| MACD | -1.02 | 1.86 |
| Stochastic Oscillator | 14.14 | 75.15 |
Viking Holdings Ltd is a travel company, with a fleet of 92 small ships, which view as floating hotels. It offers travel experiences on all seven continents in all three categories of the cruise industry river, ocean, and expedition cruising. The Group defines its products based on the type of cruise offering and language of the cruise service. The River segment provides river cruises outside the United States to English-speaking passengers. The Ocean segment offers ocean cruises to English-speaking passengers. Other include operating segments that are not individually reportable, consisting of expedition cruises for English-speaking passengers (Expedition), Mississippi River cruises for English-speaking passengers, and Viking China, which includes cruises for Mandarin.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.